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Abstract.  A  neuroblastoma protein related to the brain 
microtubule-associated protein,  MAP-1B,  as deter- 
mined by immunoprecipitation and coassembly with 
brain microtubules,  becomes phosphorylated when 
N2A mouse neuroblastoma cells are induced to gener- 
ate microtubule-containing  neurites.  To characterize 
the protein kinases that may be involved in this in vivo 
phosphorylation of MAP-1B,  we have studied its in 
vitro phosphorylation. 
In brain microtubule protein,  MAP-1B appears to be 
phosphorylated in vitro by an endogenous casein 
kinase II-like activity which also phosphorylates the 
related protein MAP-1A but scarcely phosphorylates 
MAP-2.  A  similar kinase activity has been detected in 
cell-free extracts of differentiating  N2A cells. 
Using brain MAP preparations devoid of endoge- 
nous kinase activities and different purified protein ki- 
nases,  we have found that MAP-IB is barely phos- 
phorylated by cAMP-dependent protein kinase,  Ca/ 
calmodulin-dependent protein kinase,  or Ca/phospho- 
lipid-dependent protein kinase whereas MAP-1B is one 
of the preferred substrates,  together with MAP-1A,  for 
casein kinase II. 
Brain MAP-1B phosphorylated in vitro by casein 
kinase II efficiently coassembles with microtubule 
proteins in the same way as in vivo phosphorylated 
MAP-1B from neuroblastoma cells. Furthermore,  the 
phosphopeptide patterns of brain MAP-1B phosphory- 
lated in vitro by either purified casein kinase II or an 
extract obtained from differentiating neuroblastoma 
cells are identical to each other and similar to that of 
in vivo phosphorylated neuroblastoma MAP-lB. 
Thus,  we suggest that the observed phosphorylation 
of a protein identified as MAP-1B during  neurite out- 
growth is mainly due to the activation of a casein ki- 
nase II-related activity in differentiating neuroblastoma 
cells. This kinase activity, previously implicated in 
13-tubulin phosphorylation (Serrano,  L., J.  Dfaz-Nido, 
E  Wandosell, and J.  Avila,  1987. J.  Cell Biol.  105: 
1731-1739),  may consequently have an important  role 
in posttranslational  modifications of microtubule pro- 
teins required for neuronal  differentiation. 
N 
EUROBLASTOMA  cell cultures constitute a good model 
system  for  the  study  of neuronal  differentiation. 
Most neuroblastoma  tumors  arise  in  early  child- 
hood from neuroblast precursors  of sympathetic  neurons, 
and it has been suggested  that these neoplasms  may result 
from defective differentiation  of neural crest derivatives that 
continue proliferating.  A large number of cloned cell lines 
have been derived from neuroblastomas  of mouse, rat,  and 
human  origin.  Of these,  the murine C1300 clones are the 
best characterized.  Different  treatments  (hypertonic  medi- 
um,  serum deprivation,  dibutyryl-cAME etc.) can induce 
differentiation  in these neuroblastoma cell cultures (32, 34). 
Although  the various clonal cell lines differ in their degree 
of maturation,  most neuroblastoma cells become amitotic, 
lose their oncogenic capacity and express characteristics  of 
mature neurons such as the extension  of neurites,  develop- 
ment of electrically excitable membranes, activation of neu- 
ron-specific  enzymes involved in neurotransmitter  metabo- 
lism,  etc. (32, 34). 
In differentiating  neuroblastoma cells, it has been estab- 
lished that  increased microtubule assembly occurs during 
process extension (2,  14, 30).  Moreover,  it has been shown 
that neurite outgrowth  is abolished by drugs that inhibit mi- 
crotubule assembly (9, 35, 49). Thus, neurite extension and 
maintenance  seem to  be dependent on the  assembly and 
stabilization  of internal microtubule arrays. It has been pro- 
posed that such an assembly and stabilization  could be trig- 
gered by nerve growth factor or other neurotrophic  factors 
by two distinct mechanisms  (6, 18, 27). One involves the en- 
hanced expression  of genes coding  for microtubule-associ- 
ated proteins  (MAPs), ~ such as tau  and MAP-1 (14), and 
takes place in cells that have never been exposed to neuro- 
1. Abbreviation  used in this paper:  MAP, microtubule-associated protein. 
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cells or neurons at very early ontogenetic stages. The second 
occurs in "primed" PC12 cells, sensory and sympathetic neu- 
rons, and most types of neuroblastoma cells, including the 
most undifferentiated "round-cell" neuroblastomas with no 
features of maturation, since these cell types have accumu- 
lated a critical amount of these MAPs (1, 27, 48). This mech- 
anism does not require protein synthesis and seems to be 
mediated by posttranslational modifications, mainly phos- 
phorylation, which could control the function of MAPs in 
promoting microtubule assembly and stabilizing assembled 
microtubules.  Among the  MAPs  that are  phosphorylated 
during neurite outgrowth, MAP-1 (a group of polypeptides 
that differ in their structure and cell localization [4, 23, 38, 
44]) has been the most widely described in various cell lines, 
such as the PC12  rat pheochromocytoma and Nl15 mouse 
neuroblastoma cells (7, 17, 19, 20). At present, it is unknown 
which MAP-1 polypeptide is phosphorylated during neurite 
outgrowth and which kinase is involved in that process. 
In this report, we have promoted neurite outgrowth in N2A 
mouse neuroblastoma cells by serum withdrawal and studied 
whether MAP-1 is phosphorylated. To identify the kinase in- 
volved in in vivo MAP-1 phosphorylation, we have analyzed 
the in vitro phosphorylation of MAP-1 polypeptides in mi- 
crotubule  protein  preparations  and  used  purified protein 
kinases and extracts of differentiating neuroblastoma cells. 
Finally, we  have compared  the  characteristics of in  vivo 
phosphorylated MAP-1 with those of the in vitro phosphory- 
lated protein. A preliminary account of these results has been 
reported in abstract form (12). 
Materials and Methods 
Cell Culture 
N2A mouse neuroblastoma cells (ATCC CCL 131, American Type Culture 
Collection,  Rockville,  MD)  were grown in  Dulbecco's modified Eagle's 
medium (DME) supplemented with 10%  fetal bovine serum, and induced 
to differentiate by transfer to DME without serum. 
Preparation of  Phosphorylated MAPs  from 
Differentiating N2A Cells 
100-ram culture dishes of differentiating N2A cells were rinsed with DME 
containing one-tenth the normal phosphate concentration and  incubated 
overnight in the same medium to which 1 mCi/m132PO 4 (HCI- and carrier- 
free) (Amersham Corp., Arlington Heights, IL) had been added. Cells were 
then washed with 10 mM phosphate buffer, pH 7.2, containing 150 mM NaCI 
(PBS) and gently scraped from the culture dish with a rubber policeman 
into 1 ml of cold PBS, centrifuged for 2 min at  1,000 g, and resuspended 
in 100 lal of buffer A (0.1 M 4-morpholinoethane sulfonic acid [MES], 0.5 
mM MgCI2,  and 2.5  mM EGTA,  pH 6.4)  supplemented with  10 ktg/ml 
aprotinin, 10 I.tg/ml pepstatin A, 10 I~g/ml leupeptin, 1 mM PMSE 20 mM 
NaE and 1 mM ATP. The cells were then homogenized with a teflon-glass 
homogenizer, the cell homogenates were centrifuged in a Beckman Instru- 
ments, Inc. (Fullerton, CA) airfuge (5 min at 100,000 g, 4°C), and the super- 
natants were collected. The labeled cell extracts were fractionated by chro- 
matography on a phosphocellulose column under the conditions described 
by Weingarten et al. (47). The column was washed extensively with buffer 
A  and the fractions containing neuroblastoma MAPs eluted with 0.5  M 
NaCl in buffer A, dialyzed against buffer A, and copolymerized with added 
brain microtubule protein in the presence of 1 mM GTP,  1 mM ATP, 20 mM 
NaE  10 ~g/ml aprotinin,  10 p.g/ml pepstatin A, 10 tag/ml leupeptin, and 1 
mM PMSE After centrifugation in a Beckman airfuge (5 rain at 100,000 g, 
25°C),  the pellet containing copolymerized phosphorylated N2A MAPs 
was subjected to SDS-PAGE. 
Immunoprecipitation of  In Vivo  Phosphorylated 
MAP-1  from Labeled Cell Extracts 
Immunoprecipitation of MAP-1  from labeled cell extracts was performed 
essentially as described by Gard and Kirschner (17), using the monoclonal 
antibody from clone 8D12  (IgM) (a generous gift of Dr.  I.  V. Sandoval) 
(5,  11). 
Briefly, the labeled cell extract was brought to 100 I11 with immunopre- 
cipitation buffer (50 mM Tris-HCl [pH 7.5], 2 mM EGTA, 150 mM NaC1, 
20 mM NaF,  1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS,  1 
mM ATP,  10 g.g/ml aprotinin, 10 I.tg/ml pepstatin A,  10 v.g/ml leupeptin, 
and 1 mM PMSF) and preadsorbed for 5 min with 100/.tl of 10% Staphylo- 
coccus  aureus  (Pansorbin) (Calbiocbem-Behring Corp., San Digeo, CA). 
After centrifugation to remove S.  aureus,  100 I.tl of 8D12 hybridoma-con- 
ditioned culture medium (in immunoprecipitation buffer) was added. The 
sample was incubated 1 h on ice, followed by addition of 4  V.1 of a rabbit 
anti-mouse immunoglobulin (IgA, IgG, and IgM, the kind gift of Dr. L. 
Kremer) and was reincubated for 1 h on ice. Subsequently, 100 I.tl of 10% 
S.  aureus  was added and the sample was incubated for 10 min on ice. The 
sample was then centrifuged and the S.  aureus pellet was washed five times 
in immunoprecipitation buffer. The S. aureus pellet was finally resuspended 
in  SDS  sample buffer (1%  [wt/vol]  SDS,  2%  2-mercaptoethanol,  10% 
[vol/vol]  glycerol), and subjected to SDS-PAGE. 
Protein Preparations 
Microtubule protein from pig or mouse brain was prepared by temperature- 
dependent cycles of  assembly-disassembly  according to Shelanski et al. (37) 
and stored in buffer A containing 50% glycerol at -70°C. MAPs were ob- 
tained from these preparations by chromatography on phosphocellulose 
columns as described by Weingarten et al. (47).  In some cases, these tu- 
bulin-free MAP preparations were brought to 1 M NaCI and 10 mM dithio- 
threitol (DTT) in buffer A, incubated in a boiling water bath for 5 rain, 
chilled in ice for 5 min, and centrifuged at 30,000 g for 30 min at 2°C, as 
described by Vallee (43). The resulting supernatant contained MAPs with 
no associated protein kinase activity and was used as a substrate for protein 
kinase assays.  Alternatively, brain  MAP preparations were obtained by 
phosphocellulose chromatography of microtubule protein pretreated with 
alkaline phosphatase (see below) and heat treatment was omitted. 
Casein kinase II was purified from rat liver according to the method of 
Meggio et al.  (29).  The Ca2+/calmodulin-dependent protein kinase from 
porcine brain was obtained by the procedure described by Wandosell et al. 
(46). The Ca2+/phospholipid-dependent protein kinase from porcine brain 
was obtained by the method described by Walsh et al. (45). Calmodulin was 
purified from porcine brain homogenates by the procedure of Dedman et al. 
(10).  The  cAMP-dependent protein  kinase  was  purchased  from  Sigma 
Chemical Co.  (St. Louis, MO). 
Phosphatase Treatment 
Alkaline  phosphatase from calf intestine (Boehringer Mannheim,  Indi- 
anapolis, IN) was added to microtubule protein or MAP preparations (0.2 
U/I.tg of substrate) in buffer A and incubated for 30 min at 37°C.  For MAP 
preparations, phosphatase was inactivated by placing the sample in a boiling 
water bath for 2 min. For microtubule protein, phosphatase was removed 
by an additional cycle of polymerization as previously described (36). 
Endogenous Phosphorylation of  Brain 
Microtubule Protein 
Purified brain microtubule protein (2 mg/ml), in some cases pretreated with 
alkaline phosphatase, was incubated for 15 rain at 37°C in buffer A without 
EGTA and containing 5 mM MgCI2 and  10 p.M [y-32P]ATP (Amersham 
Corp.). These assays were also performed in the presence of 10 p.M heparin 
alone;  1 mM CaCI2 alone;  1 mM CaCI2 and 1 mg/ml calmodulin;  1 mM 
CaCI2 and 80 p.g/ml phosphatidylserine; or 10 laM cAMP, as indicated in 
Results. Phosphorylation assays were stopped with SDS-sample buffer. 
In Vitro Phosphorylation of  Brain MAP Preparations 
with Purified Protein Kinases 
The purified brain MAP preparations devoid of  endogenous kinase activities 
were phosphorylated with purified casein kinase II, Ca2+/calmodulin-de  - 
pendent protein kinase II, Ca2+/phospholipid-dependent protein kinase, or 
cAMP-dependent protein kinase. 
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kinase II (1  lag) was performed in the presence of 5  mM MgCl2,  1 mM 
PMSE and l0 laM [y-32p]ATP in a final volume of 100 Bl. The Ca2+/cal - 
modulin-dependent phosphorylation of MAPs was done with 25 Bg of the 
purified kinase and 2  ~g of caimodulin in buffer A  without EGTA,  sup- 
plemented with  1 mM MgCl2, 2  mM 13-mercaptoethanol,  1 mM CaCI2, 
1  mM  PMSE  and  l0  IxM  ['/-32p]ATP  in  a  final  volume  of  100  ~tl. 
Ca/phospholipid-dependent  phosphorylation of MAPs with purified kinase 
C was performed in buffer A without EGTA, and supplemented with 5 mM 
MgCl2, 1 mM CaCl2,  80 I.tg/ml phosphatidyl serine, 1 mM PMSE l0 p.M 
[~/-32p]ATE The phosphorylation of MAPs with purified cAMP-dependent 
protein kinase was performed in buffer A supplemented with 5 mM MgCl2, 
10 BM cAME  1 mM PMSE and  10 I.tM ['/-32p]ATE 
Phosphorylation reactions were stopped by addition of boiling SDS sam- 
ple buffer. 
In Vitro Phosphorylation of  Brain MAP Preparations 
with Neuroblastoma Cell Extracts 
Undifferentiated or differentiating neuroblastoma cells were washed with 
PBS and scraped from the culture dishes in 100 I~l of buffer A supplemented 
with 20 mM NaE  20 mM Na3VO4, 10 mM MgCI:, and  10 mM PMSE 
The ceils were homogenized with a teflon-glass homogenizer and the result- 
ing homogenate centrifuged in a  Beckman airfuge (5 min at  100,000  g, 
4°C). Aliquots of the supernatants containing the same amount of protein 
were mixed with purified brain MAPs (20 ~tg in buffer A), brought to a final 
volume of 100 ~tl with buffer A, and the phosphorylation assays performed 
in the presence of 5 mM MgCI2,  1 mM PMSE and  10 IxM [~'-32p]ATP. 
Phosphorylation reactions were stopped by addition of SDS sample buffer. 
Polymerization Assays 
Microtubule protein was assembled by incubation at 37°C for 30 rain in 
buffer A in the presence of 1 mM GTP. The sample was layered onto a cush- 
ion of 40% (wt/vol) sucrose in buffer A and centrifuged in a Beckman air- 
fuge (7 min at  100,000 g).  The polymerized and unpolymerized proteins 
were boiled in the presence of 1% (wt/vol) SDS, 2% I~-mercaptoethanol, 
and  10%  (vol/vol) glycerol and subjected to electruphoresis. 
Gel Electrophoresis 
SDS-PAGE was performed according to the procedure of Laemmli (26), and 
gels were stained with Coomassie Blue as indicated by Fairbanks et al. (16). 
Phospholabeled proteins were detected by autoradiography of dried gels ex- 
posed to  Kodak-X-Omat films.  The  radioactivity associated with phos- 
phorylated MAP-1 was determined by measuring the Cerenkov radiation of 
the excised phospholabeled band in a scintillation spectrophotometer  (Beck- 
man Instruments, Inc.). 
Phosphopeptide Mapping 
Limited proteolysis of phosphorylated MAP-1 with S.  aureus  V8 protease 
was performed according to the method of Cleveland et al. (8), as described 
previously for MAP-2 (22).  Essentially, each phospholabeled protein band 
was cut out from the gel, mixed with 100 I.tg of bovine serum albumin (BSA), 
and placed in a 4% polyacrylamide stacking gel. The protein mixture was 
cleaved in the stacking gel with V8 protease (1 lag) for 30 min, and the result- 
ing phosphopeptides were separated on a  15%  polyacrylamide gel. 
Extensive trypsin digestions of the phospholabeled MAP-1 bands were 
also performed as described by Herrmann et al. (23). The resulting phos- 
phopeptides, in 0.1%  (vol/vol) trifluoroacetic acid,  were applied to a  re- 
verse-phase HPLC  column (NOVAPACK C-18;  Waters  Millipore Corp., 
Bedford, MA) and fractionated using a 0-80% acetonitrile gradient in 0.1% 
trifluoroacetic acid with a flow rate of 0.5 ml/min for 260 min. Fractions 
of 0.5 ml were collected and the associated radioactivity was determined by 
measuring Cerenkov radiation. 
Phosphoamino Acid Analysis 
MAP-1 phosphopeptides were eluted from gel slices with S. aureus  V8 pro- 
tease as described above and were hydrolyzed in 6 N HCI for 2 h at 100°C. 
Samples were spotted on cellulose thin-layer chromatography plates (East- 
man Kodak Co., Rochester, NY) and electrophoresed in acetic acid/pyri- 
dine/water (50:5:945) for 60 min at 900 V. Phosphoamino acids were de- 
tected by autoradiography and unlabeled standards were located by staining 
with  1%  ninhydrin. 
Immunofluorescence Microscopy 
N2A cells were grown on glass coverslips and induced to differentiate by 
serum withdrawal. After 1 d of serum deprivation, they were fixed for 10 
min with cold methanol. The cells were then washed with PBS, followed 
by a  1-h incubation with 8D12 hybridoma-conditioned culture medium. 
They  were then washed with PBS,  incubated 30  rain with fluorescein- 
conjugated goat anti-mouse IgM (Cappel Laboratories, West Chester, PA), 
and washed again with PBS and the coverslips mounted on glass slides using 
glycerol (90%  in PBS). 
Results 
Phosphorylation of  a Neuroblastoma Protein Related to 
Brain MAP-1B  during Neurite Outgrowth 
N2A mouse neuroblastoma cells develop neurites upon se- 
rum withdrawal.  Within  1 h,  most cells extend short pro- 
cesses; long neurites, which are stained with the monoclonal 
antibody 8D12 (5), are found after 1 d of serum deprivation 
(Fig.  1 A). 
Phosphorylation of a  MAP related to MAP-1  coupled to 
neurite outgrowth has been described for other neuroblas- 
toma cell lines  (17); we have therefore studied whether a 
similar modification occurs in N2A cells, to identify which 
component of MAP-1  is involved. Fig.  1 shows that a high- 
molecular-weight MAP becomes phosphorylated in differen- 
tiating N2A cells. Such a phosphoprotein has been identified 
as a MAP by coassembly with pig brain microtubules (Fig. 
1 B). We suggest this protein represents the neuroblastoma 
counterpart to brain MAP-IB,  since both proteins have the 
same  electrophoretic mobility and  are  recognized by the 
monoclonal antibody 8D12 (Fig. 1 B) previously reported as 
specific for MAP-1B (12). Moreover, both proteins have simi- 
lar peptide maps (see below). 
To quantitate the level of phosphorylated MAP-1B during 
neuroblastoma cell differentiation, N2A cells were labeled 
overnight with  32po4  after 0-48  h  of serum  deprivation. 
The amount of phosphorylated MAP-1B was determined by 
immunoprecipitation from aliquots of labeled cell extracts 
containing equal amounts of TCA-precipitable 32po4 counts 
with the monoclonal antibody 8D12 as indicated in Materials 
and Methods.  Fig.  2  shows a  four- to fivefold increase in 
phosphorylated MAP-1B, the major portion of which occurs 
during the first 12 h after serum withdrawal.  In this time, 
neurite  extension  is  clearly  seen.  Inclusion  of colcemid, 
which abolishes neurite outgrowth, during the labeling of 
N2A cells does not affect MAP-1B phosphorylation (Fig.  1 
C). This indicates that MAP-1B phosphorylation is not cou- 
pled to microtubule assembly. On the other hand, no differ- 
ences in the  level of MAP-1B  are observed after [35S]me- 
thionine labeling  (data not shown).  Thus,  the  increase in 
phosphorylated MAP-1B is not due to protein synthesis but 
to enhanced phosphorylation. This must be the consequence 
of an increased MAP-1B kinase activity by activation of the 
kinase itself or inhibition of a MAP-1  phosphatase activity. 
In Vitro Phosphorylation of  MAP-1B in Brain 
Microtubule Preparations 
Since some pioneering works reported an association of pro- 
tein kinase activity with microtubules assembled in vitro (15, 
31,  33,  39),  several reports have dealt with the character- 
ization of a cAMP-dependent protein kinase (42), a Ca/cal- 
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sociated  protein  MAP-1B  in  differentiating 
N2A neuroblastoma cells. (A) Immunofluores- 
cent  image  of  N2A  neuroblastoma  cells  by 
8D12 antibody after l  d of serum deprivation. 
Bar, 25  ~tm.  (B) Phosphorylated MAPs from 
differentiating N2A cells were prepared as de- 
scribed  in  Materials  and  Methods  and  sub- 
jected  to  SDS-PAGE.  Lane a  corresponds to 
the Coomassie Blue-stained pattern of mouse 
brain MAPs; the positions of MAP-IA, MAP- 
IB,  and MAP-2 are  indicated.  Lanes b  and c 
correspond to the autoradiographies of the su- 
pernatant  (lane b)  and  the  pellet  (lane  c)  of 
32p-labeled neuroblastoma proteins copolymer- 
ized  with  brain microtubule protein.  Lane d 
shows  that the  325-kD  phosphoprotein iden- 
tiffed as a  MAP comigrating with MAP-1B is 
immunoprecipitated from labeled cell extracts 
with the monoclonal antibody 8D12.  (C)  Ex- 
tracts from N2A cells labeled in the presence 
(lanes b and d) or in the absence (lanes a  and 
c) of 2 IXM colcemid after 0  (lanes a  and b) or 
24 h (lanes c and d) of serum deprivation were 
immunoprecipitated with the monoclonal anti- 
body  8D12  showing  that  colcemid  does  not 
affect MAP-1B phosphorylation. 
Table L Quantitation of  Radioactivity Associated with High-Molecular-Weight MAPs upon Addition of 
[7-32P]ATP to Brain Microtubule Protein 
Protein  Calcium and  Calcium and 
No addition  Heparin  inhibitor  calmodulin  phosphatidylserine  cAMP 
Untreated 
MAP-IA  1 (3,932 cpm)  0.32  1.06  i.05  1.01  1.03 
MAP-1B  1 (3,234 cpm)  0.41  1.05  1.01  1.01  1.02 
MAP-2  1 (25,265  cpm)  0.87  0.61  1.41  1.37  1.74 
Treated with alkaline phosphatase 
MAP-1A  1 (5,048 cpm)  0.20  0.87  0.97  1.01  1.27 
MAP-1B  1 (6,731  cpm)  0.18  0.83  0.87  0.98  1.23 
MAP-2  1 (36,580 cpm)  0.78  0.41  1.51  0.69  2.12 
Brain microtubule protein was phosphorylated using the endogenous kinase activities as indicated in Materials and Methods and subjected to SDS-PAGE. The 
radioactivity associated with each phospholabeled band was measured. The ratio of counts incorporated is indicated in the presence of heparin, the protein inhibitor 
of cAMP-dependent protein kinase, calcium and calmodulin, calcium and phosphatidylserine (PS), or cAMP, relative to those incorporated in the absence of these 
molecules. Microtubule proteins were untreated or previously treated with alkaline phosphatase. Standard deviations were in all cases under 0.05. 
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Figure 2. Increase in the level of phosphorylated MAP-IB during 
neuroblastoma cell differentiation determined by immunoprecipita- 
tion from aliquots of cell extracts labeled overnight with 32PO4 af- 
ter 0-48 h of serum withdrawal as indicated in the text. Error bars 
represent standard deviations (n  =  5). 
modulin-dependent protein kinase (41), and a casein kinase 
II-like activity (36) in these preparations. Different specific 
inhibitors and  activators let us identify the preferred sub- 
strates for these protein kinases in microtubule protein. Ta- 
ble I shows that the in vitro phosphorylation of  brain MAP-1B 
is inhibited by heparin, a known inhibitor of casein kinase 
II (21), and is barely affected by modulators of other kinase 
activities. The same is observed for MAP-1A whereas the in 
vitro phosphorylation of MAP-2 is strongly affected by mod- 
ulators of cAMP-dependent protein kinase, Ca/calmodulin- 
dependent protein kinase,  and  Ca/phospholipid-dependent 
protein kinase and  scarcely inhibited by heparin.  Thus,  a 
casein kinase II-like activity is the only one that preferen- 
tially phosphorylates MAP-1B,  together with  MAP-1A,  in 
microtubule protein. This appears even more evident when 
microtubule protein is pretreated with phosphatase. Interest- 
ingly, the fact that the level of phosphorylated MAP-1B  in- 
creases upon phosphatase treatment (see Table I) indicates 
that MAP-1B contains bound phosphate when purified from 
brain. Moreover, the above-mentioned casein kinase II-like 
activity can replace phosphate residues released previously 
by the phosphatase treatment. With respect to other protein 
kinases, it appears that cAMP-dependent protein kinase could 
be responsible  for only a  very minor fraction of in  vitro 
MAP-1B  phosphorylation in microtubule protein, differing 
from MAP-2 (see Table I). 
Figure 3. Phosphorylation of brain MAPs by cell-free lysates ob- 
tained from N2A neuroblastoma cells. Brain MAPs devoid of en- 
dogenous kinase activities were incubated in the presence (lanes b 
and d) or in the absence (lanes a and c) of 10 ItM heparin with cell 
extracts obtained from proliferating (lanes a and b) or differentiat- 
ing N2A cells (lanes c and d). An aliquot of the sample shown in 
lane b was immunoprecipitated with the monoclonal antibody 8D12 
to better visualize phosphorylated MAP-1B (lane e). 
calmodulin, or Ca2÷/phosphatidyl serine (data not shown). 
The same results are observed from brain MAP-1A,  whereas 
the in vitro phosphorylation of MAP-2 by cell-free extracts 
is barely affected by heparin. Part of the material comigrat- 
ing with MAP-2 corresponds to MAP-1B degradation prod- 
ucts, as shown by immunoprecipitation (Fig.  3, lane e). 
In cell-free lysates obtained from proliferating neuroblas- 
toma cells (Fig. 3, lanes a and b), the casein kinase II-related 
activity is  significantly reduced, suggesting that it is acti- 
vated upon serum deprivation. This points strongly to an in- 
volvement of such a liinase in neuroblastoma MAP-1B phos- 
phorylation during neurite outgrowth. 
On the other hand, MAP-1B phosphorylated in vitro with 
cell-free extracts obtained from differentiating N2A cells can 
also efficiently coassemble with microtubule protein (data 
not shown) in the same way as it will be described for MAP- 
1B phosphorylated in vitro by purified casein kinase II (see 
below). 
In Vitro Phosphorylation of  Brain MAPs 
by N2A Cell-free Extracts 
It thus appears that brain MAP-1  is mainly phosphorylated 
by a microtubule-associated casein kinase II-like activity. To 
test whether differentiating N2A neuroblastoma cells contain 
a similar protein kinase, we have studied the in vitro phos- 
phorylation by neuroblastoma cell-free extracts of brain MAP 
preparations devoid of endogenous kinase activities (obtained 
as described in Materials and Methods). 
Fig.  3  shows that cell extracts from differentiating N2A 
cells can phosphorylate brain MAPs including MAP-1B (Fig. 
3, lane c). Brain MAP-1B phosphorylation appears to be due 
to a casein kinase II-related activity, since it is inhibited by 
heparin (Fig. 3, lane d) and is not affected by cAMP, Ca2÷/ 
In Vitro Phosphorylation of  Brain MAPs with Purified 
Protein Kinases 
In microtubule preparations and neuroblastoma cell extracts, 
brain MAP-1B is mainly phosphorylated by a casein kinase 
II-related activity as indicated above. To further check these 
results,  brain  MAP preparations,  which contain MAP-1A, 
MAP-1B, MAP-2, and other MAPs, but are devoid of endog- 
enous  kinase activities,  were pretreated with phosphatase 
and incubated with several purified protein kinases (see Ma- 
terials and Methods). Among them, Ca/calmodulin-depen- 
dent protein kinase II and Ca/phospholipid-dependent pro- 
tein kinase C  does not seem to phosphorylate MAP-1B  at 
all (data not shown). Whereas cAMP-dependent protein ki- 
nase phosphorylates MAP-1B and MAP-1A to a much lower 
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cAMP-dependent protein  kinase. Brain  MAPs devoid of kinase 
activities were incubated with purified protein kinases and [y_32p]_ 
ATP as indicated in Materials and Methods and subjected to SDS- 
PAGE. Lane a  shows the Coomassie Blue-stained pattern of the 
MAP preparation. Lanes b and c correspond to the autoradiogra- 
phies of MAPs phosphorylated with casein kinase II (b) or cAMP- 
dependent protein kinase (c). 
the pellet, suggesting that there is no aggregation of MApolB 
as a consequence ofphosphorylation (data not shown). Thus, 
a  possible explanation for the presence of [32p]MAP-IB  in 
the  cold-resistant  fraction  is  their  association  with  cold- 
stable microtubules. 
It also appears  that  in  vitro phosphorylated MAP-1B  is 
found enriched 1.3-fold in the polymers assembled early dur- 
ing incubation (data not shown).  Since under these condi- 
tions, the polymers present are not microtubules (13), it is 
suggested that phosphorylated MAP-1B preferentially binds 
to large oligomers, which may be involved in microtubule 
nucleation and are especially enriched in high-molecular- 
weight MAPs. 
On the other hand, MAP-1B phosphorylation by casein ki- 
nase II occurs regardless of whether MAP-1B  is bound to 
taxol-polymerized microtubules  or  not  (data  not  shown), 
thus differing from the results for [3-tubulin (36). 
Comparison of  In Vivo Phosphorylated MAP-IB in 
N2A Neuroblastoma Cells and Mouse Brain MAP-1B 
Polypeptides Phosphorylated In Vitro 
S.  aureus V8  phosphopeptide maps of in vivo phosphory- 
lated neuroblastoma MAP-1B  and brain MAP-1B  polypep- 
tides phosphorylated in vitro with purified casein kinase II 
and cAMP-dependent protein kinase were performed as indi- 
cated in Materials and Methods. V8 phosphopeptide maps of 
in vitro phosphorylated brain MAP-1A were also performed 
for comparison.  Fig.  5  shows  that the V8 phosphopeptide 
patterns of MAP-1A and MAP~IB phosphorylated in vitro are 
similar to each other. However, the V8 phosphopeptide pat- 
terns of both MAP-1B and MAP-1A phosphorylated in vitro 
extent than it phosphorylates MAP-2 (Fig. 4), casein kinase 
II phosphorylates MAP-1B and MAP-1A almost exclusively 
(Fig.  4).  MAP-2  seems  to  be  slightly phosphorylated by 
casein kinase II,  but most phospholabeled material comi- 
grating with MAP-2 (Fig. 4) corresponds to a degradation 
product of MAP-1B,  as  indicated above.  This degradation 
product has been previously reported (5,  17). 
Coassembly Properties of  Brain MAP-1B 
Phosphorylated In Vitro by Casein Kinase H 
Phosphorylation of MAP-1B by purified casein kinase II does 
not inhibit its coassembly with microtubule protein. More- 
over, phosphorylated MAP-1B is enriched twofold in twice 
cycled microtubule protein as compared with unphosphor- 
ylated MAP-1B  (data  not  shown).  The same  result is  ob- 
served for MAP-1B  phosphorylated in vitro by a  cell-free 
extract of serum-deprived neuroblastoma cells. This is con- 
sistent with the fact that in vivo phosphorylated N2A MAP-1 
can also coassemble with microtubules. 
Interestingly, in vitro phosphorylated MApolB is enriched 
almost fourfold in the cold-resistant pellet when a cycle of 
assembly-disassembly is performed. In the absence of mi- 
crotubule protein, phosphorylated MAP-1B  is not found in 
Figure 5. V8 phosphopeptide mapping of in vitro and in vivo phos- 
phorylated MAP-I polylx~ptides. The autoradiograph shown cor- 
responds to neuroblastoma MAP-1B phosphorylated in vivo (A), 
brain MAP-1B phosphorylated in vitro by purified casein kinase II 
(B), brain MAP-1A  l~hosphorylated  in vitro by_ casein kinase II (C), 
brain MAP-IB phosphorylated in vitro by cAMP-dependent pro- 
tein ldnase  (D),  and brain  MAP-IA phosphorylated  in vitro by 
cAMP-dependent  protein kinase (E). Bovine  serum albumin (66,000), 
egg albumin (45,000), carbonic anhydrase (29,000), and lysozyme 
(14,000) were used as molecular weight markers. The numbers to 
the right refer to the molecular masses (in kilodaltons) of markers. 
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Figure o.  HPLC analyses of phosphopeptides from in vivo phos- 
phorylated MAP-1B and MAP-1B phosphorylated in vitro by casein 
kinase II.  (A) HPLC phosphopeptide pattern of heated MAP-IB 
phosphorylated in vitro with a cell-free lysate obtained from dif- 
ferentiating N2A  cells. (B)  HPLC  phosphopeptide pattern  of 
heated MAP-IB phosphorylated in vitro with purified casein kinase 
II. (C) HPLC phosphopeptide pattern of unheated MAP-1B phos- 
phorylated in vitro with purified casein kinase II. (D) HPLC phos- 
phopeptide pattern of neuroblastoma MAP-IB phosphorylated in 
vivo in differentiating N2A cells. 
with cAMP-dependent protein kinase are clearly different 
from those of both MAP-1B and MAP-1A phosphorylated in 
vitro  with casein kinase II,  which is  consistent with the 
different substrate specificity of these protein kinases (40). 
Fig.  5 also shows that the phosphopeptide pattern of in 
vivo phosphorylated neuroblastoma MAP-1B is very similar 
to that of brain MAP-1B phosphorylated in vitro with casein 
kinase II. In both cases the phosphorylated residues were 
serine and threonine (data not shown). This clearly suggests 
that a casein kinase II-related enzyme is involved in neuro- 
blastoma MAP-1B phosphorylation. 
For a  further comparison,  these phosphoproteins were 
subjected to exhaustive trypsin digestion, and the resulting 
phosphopeptides were separated by HPLC. Fig. 6 shows that 
the HPLC phosphopeptide pattern of brain MAP-1B phos- 
phorylated in vitro with purified casein kinase II is essen- 
tially identical to that of brain MAP-IB phosphorylated in 
vitro  with cell-free extracts  obtained  from differentiating 
neuroblastoma cells. These neuroblastoma cell extracts there- 
fore contain a casein kinase II-related activity (as indicated 
above) which phosphorylates brain MAP-1B at the same sites 
that are phosphorylated by purified casein kinase II. 
The HPLC phosphopeptide pattern corresponding to in 
vivo phosphorylated neuroblastoma MAP-1B is similar to 
that of in vitro phosphorylated mouse brain MAP-lB. How- 
ever,  despite the fact that the same peaks are observed in 
both HPLC phosphopeptide patterns, the amounts of radio- 
activity associated with each peak are different. These differ- 
ences may be due to the fact that brain MAP preparations are 
boiled to inactivate phosphatase before performing the phos- 
phorylation reactions.  To test this possibility, brain MAP 
preparations were obtained by an alternative procedure omit- 
ting heat treatment (see Materials and Methods). These non- 
heated brain MAP preparations were phosphorylated in vitro 
by either purified casein kinase II or a  cell extract from 
differentiating neuroblastoma cells and the resulting phos- 
phorylated MAP-1B bands subjected to trypsin digestion and 
HPLC phosphopeptide mapping.  The HPLC phosphopep- 
tide patterns of unheated brain MAP-1B phosphorylated by 
either purified casein kinase II or a neuroblastoma cell ex- 
tract are essentially identical (not shown). Interestingly, un- 
heated brain MAP-1B phosphorylated in vitro has a HPLC 
phosphopeptide pattern notably more similar to that of in 
vivo phosphorylated neuroblastoma MAP-1B than that of in 
vitro phosphorylated brain MAP-1B which has previously 
been heated (Fig. 6). The main points are the reduction in 
the amount of radioactivity associated with the two peaks 
eluting betwen 80 and 100 min and the increased proportion 
of radioactivity associated with the peak eluting around 145 
min in the HPLC phosphopeptide pattern of unheated brain 
MAP-1B when compared to that of brain MAP-1B which has 
previously been heated. These differences may therefore be 
due to heat-induced conformational changes which could ex- 
pose new phosphorylation sites. 
Discussion 
It has been suggested that posttranslational modifications of 
microtubule proteins are involved in the formation of mi- 
crotubule arrays which are necessary for neurite extension 
and maintenance in differentiating neuroblastoma cells. In 
neuronal cells induced to differentiate, the phosphorylation 
of 13-tubulin and MAP-l, among other MAPs, has been de- 
scribed (7, 17, 19, 20, 36). We have previously reported that 
a  casein  kinase  II-related  activity  should be  considered 
responsible for 13-tubulin phosphorylation in differentiating 
N2A neuroblastoma cells (36).  Here we suggest that such a 
kinase can also be involved in neuroblastoma MAP-1B phos- 
phorylation. 
We have found that casein kinase II is the only kinase 
that primarily phosphorylates brain MAP-1B, together with 
MAP-1A,  rather than MAP-2,  which is the preferred sub- 
strate for other protein kinases in vitro. Thus, it appears that 
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phosphorylation mechanisms. In this context, it has been de- 
scribed that phosphorylation of MAP-2 results in a decreased 
interaction with microtubules (24), whereas phosphorylated 
MAP-1B shows a similar or even higher affinity for microtu- 
bules than unphosphorylated MAP-lB. 
In addition to its increased binding to microtubules, phos- 
phorylated MAP-1B is enriched in the cold-resistant fraction, 
which might represent an association with cold-stable micro- 
tubules, and is also enriched in polymers found early in the 
assembly process. These polymers may serve as "seeds" of 
microtubule assembly in vitro and could constitute the in 
vitro counterpart of the stable microtubule fragments found 
in  axons  after  depolymerization (3,  25).  Thus,  MAP-1B 
phosphorylation  may  favor  microtubule  nucleation  and 
stabilization which is consistent with the fact that neuroblas- 
toma MAP-1B becomes phosphorylated in vivo during neu- 
rite outgrowth. 
Interestingly, a casein kinase II-related activity that can 
phosphorylate brain MAP-1B  in vitro in the same way as 
purified casein kinase II appears to be activated in neuroblas- 
toma cells after serum deprivation. 
However, both purified casein kinase II and the casein ki- 
nase II-related activity detected in neuroblastoma cell-free 
extracts phosphorylate both brain MAP-1B and MAP-1A  in 
vitro, whereas only MAP-1B  is phosphorylated in vivo in 
N2A  neuroblastoma  cells.  With  respect  to  this  point,  it 
should be stressed that brain MAP-1A and MAP-1B are dis- 
tinct but related proteins (4, 23, 44). Here we show that their 
phosphopeptide patterns are very similar, despite the differ- 
ences in their silver-stained peptide patterns (4). We are now 
studying whether the phosphorylation sites are scattered on 
the molecules or clustered in defined regions. If the latter is 
the case, as suggested by V8 phosphopeptide mapping, it will 
imply that MAP-1A  and MAP-1B  share some homologous 
regions  which  contain  the  phosphorylation  sites.  In  this 
context, it has been described that a monoclonal antibody 
recognizing a phosphorylated epitope reacts with both brain 
MAP-1A and MAP-1B (28). The fact that differentiated neu- 
roblastoma cells only contain phosphorylated MAP-1B prob- 
ably reflects the different distribution of MAP-1 polypeptides 
in neurons. Whereas MAP-1B is a major component of ax- 
onal cytoskeleton (4),  MAP-1A  appears to be localized to 
dendrites together with MAP-2 (38). In this way, serum dep- 
rivation would make neuroblastoma cells generate axonlike 
processes in which MAP-1B  is a major component. Since 
brain MAP-1A is also a phosphoprotein, its phosphorylation 
may be connected with later events in neuronal differentia- 
tions that are not observed in neuroblastoma cell cultures. 
On the other hand, the fact that the phosphopeptide pat- 
terns of brain MAP-1B phosphorylated in vitro by purified 
casein kinase II or cell extract are identical to each other 
clearly indicates that the cell extract contains a casein kinase 
II-related enzyme which may be involved in neuroblastoma 
MAP-1B phosphorylation. The quantitative differences ob- 
served in the otherwise similar phosphopeptide patterns of 
brain MAP-1B phosphorylated in vitro by casein kinase II 
and neuroblastoma MAP-1B phosphorylated in vivo might be 
due to the conditions required to purify MAPs and perform 
phosphorylation assays. 
In view of these results, we suggest that the neuroblastoma 
protein identified as MAP-1B is phosphorylated by a protein 
kinase similar to casein kinase II which is activated in N2A 
neuroblastoma cells after serum withdrawal. 
As  indicated above, this kinase has previously been in- 
volved in  13-tubulin phosphorylation (36).  However, there 
are some differences between 13-tubulin and MAP-1B phos- 
phorylation. Casein kinase II preferentially phosphorylates 
tubulin in the polymerized form, whereas MAP-1B is phos- 
phorylated by casein kinase II regardless of its binding to 
tubulin.  Furthermore,  colcemid  (and  other  microtubule- 
depolymerizing drugs) prevents 13-tubulin phosphorylation 
in differentiating neuroblastoma cells (17, 36) whereas MAP- 
1B phosphorylation is  not affected. Thus,  MAP-1B  phos- 
phorylation may be a prior step to 13-tubulin phosphorylation 
in differentiating neuroblastoma cells.  In this way, the se- 
quential action on MAP-1B and I~-tubulin of a casein kinase 
II-related activity, whose mechanism of activation remains 
to be established, could play an essential role during neu- 
ronal differentiation, since it might initiate microtubule as- 
sembly and stabilize the resulting microtubules inside de- 
veloping axons. 
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